Rare Presentation of Rituximab-induced Interstitial Lung Disease in a Patient with Pemphigus Vulgaris.
A 42-year-old female with a history of pemphigus vulgaris was started on rituximab after an inadequate response to corticosteroids. One month following the second cycle of rituximab, she developed acute interstitial pneumonia, which was linked to rituximab since a thorough workup revealed no evidence of an infectious cause. We initiated her on broad-spectrum intravenous (IV) antibiotics and antifungals, but the patient responded significantly to pulse methylprednisolone therapy.
Authors
- Mario Mekhail
- R. Bhalla
- Alla Sai Santhosha Mrudula (ORCID: https://orcid.org/0000-0001-5700-6743)
- Kattamreddy Ananth Rupesh (ORCID: https://orcid.org/0000-0003-1525-3740)
- Srija Sirineni
- Pravin Panditrao Kalyankar (ORCID: https://orcid.org/0000-0002-6187-8138)
- Abhinav Vulisha
- Deekshitha Alla (ORCID: https://orcid.org/0000-0003-4234-6141)
- Nikhil Gupta (ORCID: https://orcid.org/0000-0001-7265-8168)
Institutions
- Andhra University (IN)
- Texas Tech University (US)
- Gandhi Medical College & Hospital (IN)
- The University of Texas at El Paso (US)
- Fortis Escorts Hospital (IN)
- New York University Langone Orthopedic Hospital (US)
- Osmania Medical College (IN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.59556/japi.73.0916
- Citations
- 1
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47